EASL 2017

Gregory Dore at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.comGregory Dore at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com

Liver cancer

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies.

Xavier Forns at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.comXavier Forns at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com

Hepatitis C treatment

New AbbVie hepatitis C combination cures 99% of people with cirrhosis.

Richard Moreau at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.comRichard Moreau at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com

Antibiotic prophylaxis

Antibiotic prophylaxis reduces the risk of short-term death in people with decompensated cirrhosis.

infohep news